| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $3.6B | $2.8B | $2.1B | $1.2B | $0.6B |
| Cost of Revenue | $1.2B | $0.9B | $0.7B | $0.5B | $0.2B |
| Gross Profit | $2.4B | $1.9B | $1.3B | $0.8B | $0.3B |
| R&D Expense | $1.8B | $1.3B | $0.8B | $0.5B | $0.2B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-1.5B | $-1.1B | $-0.8B | $-0.7B | $-0.5B |
| Net Income | $-1.3B | $-0.8B | $-0.8B | $-0.7B | $-0.5B |
| EPS (Basic) | $-3.86 | $-2.55 | $-2.50 | $-2.26 | — |
| EPS (Diluted) | $-3.86 | $-2.55 | $-2.50 | $-2.26 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $9.0B | $8.2B | $7.7B | $6.6B | $5.9B |
| Current Assets | $5.9B | $5.0B | $5.0B | $4.6B | $4.3B |
| Cash & Equivalents | $2.6B | $1.8B | $0.9B | $1.1B | $0.8B |
| Total Liabilities | $6.0B | $3.0B | $2.3B | $1.6B | $1.0B |
| Current Liabilities | $3.3B | $2.7B | $2.0B | $1.4B | $0.8B |
| Stockholders' Equity | $3.0B | $5.2B | $5.5B | $5.0B | $4.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.8B | $0.5B | $0.1B | $-0.0B |
| Investing Cash Flow | $0.2B | $0.8B | $-0.6B | $-0.0B | $-4.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.9B | $-0.1B | $0.2B | $4.8B |